Hyaluronic acid: Function and location in the urothelial barrier for bladder pain syndrome/interstitial cystitis, an in vitro study
Open Access
- 26 February 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (2) , e0318277
Abstract
Disruption of the glycosaminoglycan (GAG)-layer and urothelial barrier is an important aspect of the pathophysiology of bladder pain syndrome/ interstitial cystitis. Intravesical hyaluronic acid (HA) is often used in treatments for IC/BPS, however the role in the urothelial barrier is unknown. This study aims to clarify the location and functional contribution of HA in the urothelium, using an in vitro model. Immunohistochemistry was performed on human and porcine biopsies and on porcine cell cultures to evaluate the location of HA. Functional contribution was assessed through transepithelial electrical resistance measurements and the effects on gene expression in a differentiated primary porcine urothelial cell model. HA was found throughout in the urothelium and most abundant around the basal layer. Digestion of HA increased impermeability of the urothelium, contrasting with the effect of protamine sulfate (PS). After HA digestion, quantitative PCR analysis revealed upregulation of HA-synthesizing gene (HAS3) and the inflammatory marker (IL8). Treatment with HA and/or chondroitin sulfate therapy in undamaged cells upregulated genes related to GAG synthesis, barrier markers and inflammation. In PS-damaged cells, GAG therapy only upregulated genes associated with HA synthesis and inflammation, without affecting barrier recovery speed. These results emphasize the interaction of HA on urothelial cell inflammation and barrier repair physiology. HA seems to not directly restore the urothelial luminal GAG layer but influences barrier integrity through its interactions with urothelial cells.Keywords
Funding Information
- Goodlife Pharma
This publication has 37 references indexed in Scilit:
- Identification of Proteoglycans Present at High Density on Bovine and Human Bladder Luminal SurfaceJournal of Urology, 1994
- Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motilityJournal of Cell Biology, 1992
- Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition.Journal of Experimental Medicine, 1990
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990
- The biology of interleukin-6.1989
- Functional and Structural Characteristics of the Glycosaminoglycans of the Bladder Luminal SurfaceJournal of Urology, 1987
- The Glycosaminoglycans of Human Bladder Cancers of Varying Grade and StageJournal of Urology, 1985
- Quantitative analysis of glycosaminoglycans in urothelium and bladder wall of calfUrology, 1983
- The primary antibacterial defense mechanism of the bladder.1975
- Route of Passive Ion Permeation in EpitheliaNature New Biology, 1972